Maynard Um
-
-
-
-
-
-
-
Belite Bio (BLTE) Reiterated at Buy by Benchmark on Tinlarebant NDA Acceptance by FDA
-
-
-
-
-
-
-
Belite Bio, Inc, ADR (BLTE) PT Lowered to $215 at Mizuho
-
-
-
-
-
-
-
Bernstein on US Pharma and Biotech: Who might buy whom?
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)
-
-
-
-
-
-
-
Cantor Fitzgerald Assumes Belite Bio, Inc, ADR (BLTE) at Overweight
-
-
-
-
-
-
-
Belite Bio, Inc, ADR (BLTE) PT Lowered to $98 at H.C. Wainwright
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Belite Bio, Inc, ADR (BLTE)
-
466,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


